ARTICLE | Finance

IPO Watch

Delivery play AcelRx, derm play Moberg file IPOs

November 22, 2010 8:00 AM UTC

Neurology and drug delivery play AcelRx Pharmaceuticals Inc. filed to raise up to $86.3 million.

AcelRx's lead candidate is the Sufentanil NanoTab PCA System (ARX-01), a sublingual formulation of the synthetic opioid analgesic sufentanil that is delivered via a non-invasive, pre-programmed, handheld device. The system is expected to begin Phase III testing in 2H11...